COMT and OPRM1 Polymorphisms and Their Effect on Post-Operative Pain in Children

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age8-18
SponsorAmerican University of Beirut Medical Center

About this trial

The goal of this observational study is to investigate whether the A118G single-nucleotide polymorphism (SNP) in the mu-opioid receptor1(OPRM1) and Catechol-O-methyltransferase (COMT) SNPs influence postoperative pain scores in children between the ages of 8 and 18 undergoing orthopedic, abdominal, thoracic, and plastic surgeries.

The main question\[s\] it aims to answer \[is\]:

Do OPRM1 and COMT SNPs influence postoperative pain scores in children between the ages of 8 and 18 undergoing orthopedic, abdominal, thoracic, and plastic surgeries?

Participants will be assessed for their pain scores, sedation level, the amount of postoperative analgesics received, duration of their stay in the post-anesthesia care unit, and toxicity.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

All children 8 years to 18 years

Undergoing orthopedic, abdominal, thoracic, and plastic surgeries

American Society of Anesthesiologists classification (ASA) I-II-III

Disqualifiers

Children with schizoid personality disorders, phobias, and anxiety

Patients with neuropathic pain associated with surgeries requiring surgical treatment.

Children presented with all types of depressive disorders, atypical bipolar disorder, or a suspicion of substance abuse.

American Society of Anesthesiologists classification (ASA) ≥IV

Trial population

Children between the ages of 8-18 undergoing orthopedic, abdominal, thoracic, and plastic surgeries will be recruited from the American University of Beirut Medical Center (AUBMC).

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Pain scores

Pain scores measured using the Numerical Rating Scale (NRS) (ranging from 0 to 10, with 0 no pain and 10 worst pain)

Time frame
Until discharge from PACU (about 3 hours)

Secondary outcomes

1

Postoperative sedation

Postoperative sedation measured using the Richmond Agitation Sedation Scale (RASS) (ranging from -5 to +4, with -5 unarousable and +4 combative)

Time frame
Until discharge from PACU (about 3 hours)
2

Use of intraoperative and post-operative opioids

Use of intraoperative and post-operative opioids (Yes/No)

Time frame
Until discharge from PACU (about 3 hours)
3

Length of post-anesthesia care unit (PACU) stay

Length of post-anesthesia care unit (PACU) stay measured in hours

Time frame
Until discharge from PACU (about 3 hours)
4

Postoperative respiratory depression

Postoperative respiratory depression (Yes/No)

Time frame
Until discharge from PACU (about 3 hours)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.